Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in the company's own shares. The reporting period covers the month of July 2025, with the specific transaction date being July 30, 2025. The filing details a share repurchase executed under a non-discretionary agreement with Merrill Lynch International, acting as the corporate stockbroker.
Key Financial Metrics
The filing focuses exclusively on share repurchase activity and capital structure updates. It does not contain revenue, profit, cash flow, or margin data.
- Shares Purchased (July 30, 2025): 288,978 ordinary shares.
- Price Range: Lowest price paid was 1,386.50 GBp; highest price paid was 1,463.50 GBp.
- Volume-Weighted Average Price (VWAP): 1,432.69 GBp.
- Trading Venue: All purchases occurred on the London Stock Exchange (XLON).
- Cumulative Buyback (Since June 4, 2025): 18,435,938 ordinary shares.
- Treasury Shares Held: 236,570,321 ordinary shares.
- Shares in Issue (Excluding Treasury): 4,078,815,089 ordinary shares.
- Treasury Voting Rights: 5.80% of total voting rights.
Material Changes
Following the July 30 transaction, the total number of voting rights in the company remains 4,078,815,089. The percentage of voting rights attributable to ordinary shares held in treasury is confirmed at 5.80%. This figure serves as the denominator for shareholders calculating notification requirements under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no new financial guidance, operational outlook, or management commentary regarding business performance. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially from projections due to risks described in GSK's 2024 Annual Report on Form 20-F and Q2 2025 Results.
Investor Verification Checklist
- Verify the total number of shares in issue (4,078,815,089) for accurate calculation of ownership percentages.
- Confirm the 5.80% treasury shareholding threshold for disclosure obligations under DTR 5.5.1R.
- Review the cumulative buyback volume of 18.4 million shares since the program's inception on June 4, 2025.
- Note that the VWAP of 1,432.69 GBp reflects the execution price for the specific July 30 transaction.